Elmika 250mg Injection
Marketer
Elivia Life Sciences Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Elmika 250mg Injection
Cephalexin 250mg Injection combats bacterial infections affecting various body systems, including the urinary tract, musculoskeletal system, respiratory system (like pneumonia), central nervous system, and bloodstream. Prophylactic use is common in hospitalized individuals. This antibiotic functions by inhibiting bacterial growth. Administered intravenously or intramuscularly by a healthcare professional, it requires consistent dosing as directed. Complete the prescribed course; premature cessation may result in relapse or infection exacerbation. Typical side effects include injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness warrant medical consultation. High doses may rarely cause vertigo, nephrotoxicity, and ototoxicity, necessitating close monitoring including kidney function, hearing, and urinalysis. Pregnancy contraindicates its use; inform your physician about pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Elmika 250mg Injection
The provided text is "undefined," offering no content to rephrase.
Uses of Elmika 250mg Injection
Infections caused by bacteria
Major Benefits of Elmika 250mg Injection:
This medication will be administered by your physician or their qualified associate; please do not attempt self-medication.
Common Side effects of Elmika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Elmika 250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Elmika 250mg Injection works:
The antibiotic injection Elmika 250mg inhibits bacterial proliferation by disrupting the production of crucial proteins necessary for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Elmika 250mg Injection can be taken with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Elmika 250mg Injection during pregnancy is contraindicated due to established risks to the fetus. Exceptions may exist in critical circumstances where a physician deems the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Elmika, 250mg, presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no apparent threat to the infant.
DrivingUNSAFE
Administering Elmika 250mg Injection could induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administration of Elmika 250mg Injection requires careful monitoring. The prescribed dosage of Elmika 250mg Injection may require modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Elmika 250mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Elmika 250mg Injection :
Omit a scheduled Elmika 250mg Injection? Seek your physician's advice.
Facts to Know About Elmika 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently